Uniphar PLC (LON: UPR) announced its acquisition of BModesto Group on November 21 for nearly $52.3 million.
Founded in 2014, BModesto Group is a Dutch healthcare services firm. It offers a range of services, including the distribution of medicines, clinical trial services, market authorization holder services and medical device distribution. In 2021, it reported $7,890,498 in revenue (€7.7 million).
Uniphar is a pharmaceutical manufacturing and healthcare services organization with offices in Ireland, England and the U.S. The company was founded in 1967 and is based in Dublin, Ireland. In 2021, Uniphar generated revenue of $1,946,977,500 (€1.9 billion), gross profit of $281,287,012 (€274.5 million) and EBITDA of $88,638,712 (€86.5 million).
BModesto will be integrated into Uniphar’s Product Access division and will support the delivery of existing services into the European market.
The purchase price of $52,267,860 was converted from €51 million. A deferred consideration payment of up to $24,596,640 (€24 million) will be payable upon the achievement of earnings before interest, taxes, depreciation and amortization and gross profit performance targets.According to the LevinPro HC database, this acquisition represents the 27th healthcare product distributor transaction of the year and the third in November. The healthcare product distributor deal volume of 2022 has seen a significant increase from January 1, 2021, through November 21, 2021, that saw 14 reported transactions.
